1. Home
  2. SIMO vs BMRN Comparison

SIMO vs BMRN Comparison

Compare SIMO & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SIMO

Silicon Motion Technology Corporation

HOLD

Current Price

$300.71

Market Cap

10.4B

Sector

Technology

ML Signal

HOLD

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

HOLD

Current Price

$58.97

Market Cap

10.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SIMO
BMRN
Founded
1995
1996
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.4B
10.4B
IPO Year
2005
1999

Fundamental Metrics

Financial Performance
Metric
SIMO
BMRN
Price
$300.71
$58.97
Analyst Decision
Strong Buy
Buy
Analyst Count
9
18
Target Price
$118.13
$88.22
AVG Volume (30 Days)
877.8K
1.9M
Earning Date
04-28-2026
05-04-2026
Dividend Yield
0.92%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.54
Revenue
N/A
$1,313,646,000.00
Revenue This Year
$42.27
$15.02
Revenue Next Year
$12.78
$12.23
P/E Ratio
$36.09
$109.20
Revenue Growth
N/A
17.62
52 Week Low
$70.12
$49.26
52 Week High
$355.00
$66.28

Technical Indicators

Market Signals
Indicator
SIMO
BMRN
Relative Strength Index (RSI) 52.32 61.76
Support Level $91.95 $53.32
Resistance Level $314.34 $61.92
Average True Range (ATR) 24.43 1.49
MACD -2.00 0.19
Stochastic Oscillator 42.85 85.48

Price Performance

Historical Comparison
SIMO
BMRN

About SIMO Silicon Motion Technology Corporation

Silicon Motion Technology Corp is engaged in developing NAND flash controllers for SSDs and other solid-state storage devices. Its only operating segment is to develop NAND flash controllers and SSD solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company's products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: